Cargando…

The critical role of interleukin-6 in protection against neurotropic flavivirus infection

West Nile virus (WNV) and Japanese encephalitis virus (JEV) are emerging mosquito-borne flaviviruses causing encephalitis globally. No specific drug or therapy exists to treat flavivirus-induced neurological diseases. The lack of specific therapeutics underscores an urgent need to determine the func...

Descripción completa

Detalles Bibliográficos
Autores principales: Auroni, Tabassum T., Arora, Komal, Natekar, Janhavi P., Pathak, Heather, Elsharkawy, Amany, Kumar, Mukesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694511/
http://dx.doi.org/10.3389/fcimb.2023.1275823
_version_ 1785153394803998720
author Auroni, Tabassum T.
Arora, Komal
Natekar, Janhavi P.
Pathak, Heather
Elsharkawy, Amany
Kumar, Mukesh
author_facet Auroni, Tabassum T.
Arora, Komal
Natekar, Janhavi P.
Pathak, Heather
Elsharkawy, Amany
Kumar, Mukesh
author_sort Auroni, Tabassum T.
collection PubMed
description West Nile virus (WNV) and Japanese encephalitis virus (JEV) are emerging mosquito-borne flaviviruses causing encephalitis globally. No specific drug or therapy exists to treat flavivirus-induced neurological diseases. The lack of specific therapeutics underscores an urgent need to determine the function of important host factors involved in flavivirus replication and disease progression. Interleukin-6 (IL-6) upregulation has been observed during viral infections in both mice and humans, implying that it may influence the disease outcome significantly. Herein, we investigated the function of IL-6 in the pathogenesis of neurotropic flavivirus infections. First, we examined the role of IL-6 in flavivirus-infected human neuroblastoma cells, SK-N-SH, and found that IL-6 neutralization increased the WNV or JEV replication and inhibited the expression of key cytokines. We further evaluated the role of IL-6 by infecting primary mouse cells derived from IL-6 knockout (IL-6(−/−)) mice and wild-type (WT) mice with WNV or JEV. The results exhibited increased virus yields in the cells lacking the IL-6 gene. Next, our in vivo approach revealed that IL-6(−/−) mice had significantly higher morbidity and mortality after subcutaneous infection with the pathogenic WNV NY99 or JEV Nakayama strain compared to WT mice. The non-pathogenic WNV Eg101 strain did not cause mortality in WT mice but resulted in 60% mortality in IL-6(−/−) mice, indicating that IL-6 is required for the survival of mice after the peripheral inoculation of WNV or JEV. We also observed significantly higher viremia and brain viral load in IL-6(−/−) mice than in WT mice. Subsequently, we explored innate immune responses in WT and IL-6(−/−) mice after WNV NY99 infection. Our data demonstrated that the IL-6(−/−) mice had reduced levels of key cytokines in the serum during early infection but elevated levels of proinflammatory cytokines in the brain later, along with suppressed anti-inflammatory cytokines. In addition, mRNA expression of IFN-α and IFN-β was significantly lower in the infected IL-6(−/−) mice. In conclusion, these data suggest that the lack of IL-6 exacerbates WNV or JEV infection in vitro and in vivo by causing an increase in virus replication and dysregulating host immune response.
format Online
Article
Text
id pubmed-10694511
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106945112023-12-05 The critical role of interleukin-6 in protection against neurotropic flavivirus infection Auroni, Tabassum T. Arora, Komal Natekar, Janhavi P. Pathak, Heather Elsharkawy, Amany Kumar, Mukesh Front Cell Infect Microbiol Cellular and Infection Microbiology West Nile virus (WNV) and Japanese encephalitis virus (JEV) are emerging mosquito-borne flaviviruses causing encephalitis globally. No specific drug or therapy exists to treat flavivirus-induced neurological diseases. The lack of specific therapeutics underscores an urgent need to determine the function of important host factors involved in flavivirus replication and disease progression. Interleukin-6 (IL-6) upregulation has been observed during viral infections in both mice and humans, implying that it may influence the disease outcome significantly. Herein, we investigated the function of IL-6 in the pathogenesis of neurotropic flavivirus infections. First, we examined the role of IL-6 in flavivirus-infected human neuroblastoma cells, SK-N-SH, and found that IL-6 neutralization increased the WNV or JEV replication and inhibited the expression of key cytokines. We further evaluated the role of IL-6 by infecting primary mouse cells derived from IL-6 knockout (IL-6(−/−)) mice and wild-type (WT) mice with WNV or JEV. The results exhibited increased virus yields in the cells lacking the IL-6 gene. Next, our in vivo approach revealed that IL-6(−/−) mice had significantly higher morbidity and mortality after subcutaneous infection with the pathogenic WNV NY99 or JEV Nakayama strain compared to WT mice. The non-pathogenic WNV Eg101 strain did not cause mortality in WT mice but resulted in 60% mortality in IL-6(−/−) mice, indicating that IL-6 is required for the survival of mice after the peripheral inoculation of WNV or JEV. We also observed significantly higher viremia and brain viral load in IL-6(−/−) mice than in WT mice. Subsequently, we explored innate immune responses in WT and IL-6(−/−) mice after WNV NY99 infection. Our data demonstrated that the IL-6(−/−) mice had reduced levels of key cytokines in the serum during early infection but elevated levels of proinflammatory cytokines in the brain later, along with suppressed anti-inflammatory cytokines. In addition, mRNA expression of IFN-α and IFN-β was significantly lower in the infected IL-6(−/−) mice. In conclusion, these data suggest that the lack of IL-6 exacerbates WNV or JEV infection in vitro and in vivo by causing an increase in virus replication and dysregulating host immune response. Frontiers Media S.A. 2023-11-16 /pmc/articles/PMC10694511/ http://dx.doi.org/10.3389/fcimb.2023.1275823 Text en Copyright © 2023 Auroni, Arora, Natekar, Pathak, Elsharkawy and Kumar https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Auroni, Tabassum T.
Arora, Komal
Natekar, Janhavi P.
Pathak, Heather
Elsharkawy, Amany
Kumar, Mukesh
The critical role of interleukin-6 in protection against neurotropic flavivirus infection
title The critical role of interleukin-6 in protection against neurotropic flavivirus infection
title_full The critical role of interleukin-6 in protection against neurotropic flavivirus infection
title_fullStr The critical role of interleukin-6 in protection against neurotropic flavivirus infection
title_full_unstemmed The critical role of interleukin-6 in protection against neurotropic flavivirus infection
title_short The critical role of interleukin-6 in protection against neurotropic flavivirus infection
title_sort critical role of interleukin-6 in protection against neurotropic flavivirus infection
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694511/
http://dx.doi.org/10.3389/fcimb.2023.1275823
work_keys_str_mv AT auronitabassumt thecriticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT arorakomal thecriticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT natekarjanhavip thecriticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT pathakheather thecriticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT elsharkawyamany thecriticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT kumarmukesh thecriticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT auronitabassumt criticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT arorakomal criticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT natekarjanhavip criticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT pathakheather criticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT elsharkawyamany criticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection
AT kumarmukesh criticalroleofinterleukin6inprotectionagainstneurotropicflavivirusinfection